Spain is widely regarded as having one of the world’s best healthcare systems. Can a series of experiments in ‘value-based’ care help to make it even better? A new Science|Business report finds out
BSC has launched a new spin-off, ELEM Biotech, which will allow companies of medical technologies, pharmaceuticals, CROs and doctors to perform virtual simulations for the personalized treatment of some diseases.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and the fortnightly R&D Express, tracking reforms and investments in central and eastern Europe.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.